Search

Farley J. Abad

Examiner (ID: 14201, Phone: (571)270-3425 , Office: P/2181 )

Most Active Art Unit
2181
Art Unit(s)
2181
Total Applications
1076
Issued Applications
864
Pending Applications
101
Abandoned Applications
140

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5760092 [patent_doc_number] => 20060211037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Novel mouse CXC chemokine receptor' [patent_app_type] => utility [patent_app_number] => 11/437734 [patent_app_country] => US [patent_app_date] => 2006-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14064 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211037.pdf [firstpage_image] =>[orig_patent_app_number] => 11437734 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/437734
Mouse CXC chemokine receptor May 21, 2006 Issued
Array ( [id] => 5785277 [patent_doc_number] => 20060205002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Methods for determining plasma free drug concentration by direct measurement of binding affinity of protease inhibitors to plasma proteins' [patent_app_type] => utility [patent_app_number] => 11/429481 [patent_app_country] => US [patent_app_date] => 2006-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5744 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205002.pdf [firstpage_image] =>[orig_patent_app_number] => 11429481 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/429481
Methods for determining plasma free drug concentration by direct measurement of binding affinity of protease inhibitors to plasma proteins May 4, 2006 Abandoned
Array ( [id] => 5887724 [patent_doc_number] => 20060275322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Modified HCV peptide vaccines' [patent_app_type] => utility [patent_app_number] => 11/429670 [patent_app_country] => US [patent_app_date] => 2006-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17955 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275322.pdf [firstpage_image] =>[orig_patent_app_number] => 11429670 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/429670
Modified HCV peptide immunogens May 4, 2006 Issued
Array ( [id] => 5148222 [patent_doc_number] => 20070048281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'HCV COMBINATION THERAPY' [patent_app_type] => utility [patent_app_number] => 11/381408 [patent_app_country] => US [patent_app_date] => 2006-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17946 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20070048281.pdf [firstpage_image] =>[orig_patent_app_number] => 11381408 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/381408
HCV COMBINATION THERAPY May 2, 2006 Abandoned
Array ( [id] => 5851023 [patent_doc_number] => 20060234214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Methods of detecting hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 11/405032 [patent_app_country] => US [patent_app_date] => 2006-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7706 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234214.pdf [firstpage_image] =>[orig_patent_app_number] => 11405032 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/405032
Methods of detecting hepatitis C virus Apr 12, 2006 Abandoned
Array ( [id] => 5602348 [patent_doc_number] => 20060292693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Monoclonal antibody with the capability of neutralizing enterovirus type 71 infection' [patent_app_type] => utility [patent_app_number] => 11/403070 [patent_app_country] => US [patent_app_date] => 2006-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5184 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20060292693.pdf [firstpage_image] =>[orig_patent_app_number] => 11403070 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/403070
Monoclonal antibody with the capability of neutralizing enterovirus type 71 infection Apr 11, 2006 Issued
Array ( [id] => 5034660 [patent_doc_number] => 20070099199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Methods and compositions for treating cervical cancer' [patent_app_type] => utility [patent_app_number] => 11/403141 [patent_app_country] => US [patent_app_date] => 2006-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 54014 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099199.pdf [firstpage_image] =>[orig_patent_app_number] => 11403141 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/403141
Methods and compositions for treating cervical cancer Apr 10, 2006 Abandoned
Array ( [id] => 4778754 [patent_doc_number] => 20080286752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Methods for the production of HCV, assaying HCV entry, and screening drugs and cellular receptors for HCV' [patent_app_type] => utility [patent_app_number] => 11/400419 [patent_app_country] => US [patent_app_date] => 2006-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 32252 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286752.pdf [firstpage_image] =>[orig_patent_app_number] => 11400419 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/400419
Methods for the production of HCV, assaying HCV entry, and screening drugs and cellular receptors for HCV Apr 6, 2006 Abandoned
Array ( [id] => 585386 [patent_doc_number] => 07446177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-04 [patent_title] => 'Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection' [patent_app_type] => utility [patent_app_number] => 11/397236 [patent_app_country] => US [patent_app_date] => 2006-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 33978 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/446/07446177.pdf [firstpage_image] =>[orig_patent_app_number] => 11397236 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/397236
Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection Apr 3, 2006 Issued
Array ( [id] => 5596213 [patent_doc_number] => 20060160130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Recombinant RSV virus expression systems and vaccines' [patent_app_type] => utility [patent_app_number] => 11/389618 [patent_app_country] => US [patent_app_date] => 2006-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20968 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160130.pdf [firstpage_image] =>[orig_patent_app_number] => 11389618 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/389618
Recombinant RSV virus expression systems and vaccines Mar 23, 2006 Abandoned
Array ( [id] => 5204941 [patent_doc_number] => 20070026422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Vaccine-induced hepatitis B viral strain and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/385013 [patent_app_country] => US [patent_app_date] => 2006-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9315 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20070026422.pdf [firstpage_image] =>[orig_patent_app_number] => 11385013 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/385013
Vaccine-induced hepatitis B viral strain and uses thereof Mar 19, 2006 Abandoned
Array ( [id] => 5051392 [patent_doc_number] => 20070031937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Co-expression of recombinant proteins' [patent_app_type] => utility [patent_app_number] => 11/378739 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 9158 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031937.pdf [firstpage_image] =>[orig_patent_app_number] => 11378739 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/378739
Co-expression of recombinant proteins Mar 16, 2006 Abandoned
Array ( [id] => 299725 [patent_doc_number] => 07537924 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-26 [patent_title] => 'Virus strains' [patent_app_type] => utility [patent_app_number] => 11/372613 [patent_app_country] => US [patent_app_date] => 2006-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10788 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/537/07537924.pdf [firstpage_image] =>[orig_patent_app_number] => 11372613 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/372613
Virus strains Mar 9, 2006 Issued
Array ( [id] => 5873941 [patent_doc_number] => 20060166193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Binding protein' [patent_app_type] => utility [patent_app_number] => 11/372935 [patent_app_country] => US [patent_app_date] => 2006-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8381 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20060166193.pdf [firstpage_image] =>[orig_patent_app_number] => 11372935 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/372935
Hepatitis C virus E2 binding protein Mar 8, 2006 Issued
Array ( [id] => 5027998 [patent_doc_number] => 20070269445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a PRRSV and a method of detecting a PRRSV' [patent_app_type] => utility [patent_app_number] => 11/369944 [patent_app_country] => US [patent_app_date] => 2006-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 37610 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269445.pdf [firstpage_image] =>[orig_patent_app_number] => 11369944 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/369944
Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) Mar 7, 2006 Issued
Array ( [id] => 5760024 [patent_doc_number] => 20060210969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Infectious, chimeric hepatitis C virus, methods of producing the same and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/366839 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11305 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20060210969.pdf [firstpage_image] =>[orig_patent_app_number] => 11366839 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/366839
Infectious, chimeric hepatitis C virus, methods of producing the same and methods of use thereof Mar 2, 2006 Issued
Array ( [id] => 5520839 [patent_doc_number] => 20090028820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Antiviral Agent' [patent_app_type] => utility [patent_app_number] => 11/885418 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5642 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20090028820.pdf [firstpage_image] =>[orig_patent_app_number] => 11885418 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/885418
Antiviral Agent Mar 1, 2006 Abandoned
Array ( [id] => 5785295 [patent_doc_number] => 20060205016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Protein a based binding domains with desirable activities' [patent_app_type] => utility [patent_app_number] => 11/357443 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17403 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205016.pdf [firstpage_image] =>[orig_patent_app_number] => 11357443 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/357443
Protein a based binding domains with desirable activities Feb 15, 2006 Abandoned
Array ( [id] => 5748626 [patent_doc_number] => 20060111558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Recombinant infectious laryngotracheitis virus and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/342171 [patent_app_country] => US [patent_app_date] => 2006-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 24998 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111558.pdf [firstpage_image] =>[orig_patent_app_number] => 11342171 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/342171
Recombinant infectious laryngotracheitis virus and uses thereof Jan 26, 2006 Issued
Array ( [id] => 5912876 [patent_doc_number] => 20060127938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Immunoassay for HIV protease inhibitors' [patent_app_type] => utility [patent_app_number] => 11/341550 [patent_app_country] => US [patent_app_date] => 2006-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5602 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20060127938.pdf [firstpage_image] =>[orig_patent_app_number] => 11341550 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/341550
Immunoassay for HIV protease inhibitors Jan 25, 2006 Abandoned
Menu